Skip to content
Disclosery

Cutter Capital Management, LP

Follow

13F filer, CIK 1983313, NEW YORK, NY

Cutter Capital Management, LP reported $338,788,113 across 27 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-14. Its ten largest share positions make up 55.99% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001214659-24-019126

Period
2024-09-30
Reported value
$339M
Holdings
27
Top 10 weight
55.99%
New
12
Sold out
12

Largest buys vs the previous quarter

SecurityShares changeApprox. value
BMYnew+574,057$29.7M
Anew+120,485$17.9M
LLYnew+17,299$15.3M
REGNnew+14,476$15.2M
JAZZnew+117,500$13.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
BMRNexited-273,533-$22.5M
MRKexited-175,600-$21.7M
AMGNexited-64,201-$20.1M
BIIBexited-76,726-$17.8M
KVUEexited-960,400-$17.5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2024

Share positions as resolved from 13F-HR 0001214659-24-019126, largest first. % of portfolio is the value over $338,788,113, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
GILDGILEAD SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: not reported; 2024Q1: 265,436 shares; 2024Q2: 292,959 shares; 2024Q3: 359,025 shares 359,025$30.1M8.88%+66,066Timeline
BMYBRISTOL-MYERS SQUIBB COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: 140,000 shares; 2024Q1: 446,900 shares; 2024Q2: not reported; 2024Q3: 574,057 shares 574,057$29.7M8.77%newTimeline
RPRXROYALTY PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: 370,000 shares; 2024Q1: 411,540 shares; 2024Q2: 692,300 shares; 2024Q3: 664,859 shares 664,859$18.8M5.55%-27,441Timeline
AAGILENT TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 120,485 shares 120,485$17.9M5.28%newTimeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: 365,000 shares; 2024Q3: 286,803 shares 286,803$15.9M4.7%-78,197Timeline
LEGNLEGEND BIOTECH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: not reported; 2024Q1: 79,830 shares; 2024Q2: 343,130 shares; 2024Q3: 325,953 shares 325,953$15.9M4.69%-17,177Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: 413,499 shares; 2024Q1: 227,337 shares; 2024Q2: 227,637 shares; 2024Q3: 215,884 shares 215,884$15.8M4.65%-11,753Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: not reported; 2024Q1: 11,040 shares; 2024Q2: not reported; 2024Q3: 17,299 shares 17,299$15.3M4.52%newTimeline
REGNREGENERON PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: not reported; 2024Q1: 16,360 shares; 2024Q2: not reported; 2024Q3: 14,476 shares 14,476$15.2M4.49%newTimeline
HRMYHARMONY BIOSCIENCES HLDGS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: 295,771 shares; 2024Q3: 376,315 shares 376,315$15.1M4.44%+80,544Timeline
PRGOPERRIGO CO PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: 260,000 shares; 2024Q1: 322,114 shares; 2024Q2: 100,000 shares; 2024Q3: 557,937 shares 557,937$14.6M4.32%+457,937Timeline
JAZZJAZZ PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 117,500 shares 117,500$13.1M3.86%newTimeline
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 378,453 shares 378,453$12.1M3.58%new
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: 307,721 shares; 2024Q1: 278,638 shares; 2024Q2: not reported; 2024Q3: 518,677 shares 518,677$11.8M3.48%newTimeline
SRPTSAREPTA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: not reported; 2024Q1: 94,379 shares; 2024Q2: 89,379 shares; 2024Q3: 83,756 shares 83,756$10.5M3.09%-5,623Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: 103,324 shares; 2024Q1: not reported; 2024Q2: 311,700 shares; 2024Q3: 396,388 shares 396,388$10.1M2.98%+84,688Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 105,767 shares 105,767$9.51M2.81%newTimeline
AGIOAGIOS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: not reported; 2024Q1: 288,580 shares; 2024Q2: not reported; 2024Q3: 186,623 shares 186,623$8.29M2.45%newTimeline
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: 677,350 shares; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 876,009 shares 876,009$8.23M2.43%newTimeline
NTLAINTELLIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 390,622 shares 390,622$8.03M2.37%newTimeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: 230,000 shares; 2024Q3: 172,876 shares 172,876$7.64M2.26%-57,124Timeline
ACLXARCELLX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: not reported; 2024Q1: 107,000 shares; 2024Q2: 187,000 shares; 2024Q3: 89,863 shares 89,863$7.5M2.22%-97,137Timeline
RNAMAVIDITY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 160,947 shares 160,947$7.39M2.18%newTimeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: 1,521,812 shares; 2024Q1: 2,105,459 shares; 2024Q2: 1,975,298 shares; 2024Q3: 798,137 shares 798,137$6.07M1.79%-1,177,161Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: 222,985 shares; 2024Q3: 207,896 shares 207,896$5.31M1.57%-15,089Timeline
AVADEL PHARMACEUTICALSAVADEL PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: not reported; 2024Q1: 541,926 shares; 2024Q2: 733,001 shares; 2024Q3: 385,172 shares 385,172$5.05M1.49%-347,829
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: not loaded; 2023Q4: not reported; 2024Q1: 289,366 shares; 2024Q2: 160,166 shares; 2024Q3: 97,300 shares 97,300$3.9M1.15%-62,866Timeline

Sold out in Q3 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
BMRNBIOMARIN PHARMACEUTICAL INC273,533$22.5Mshares
MRKMERCK & CO INC175,600$21.7Mshares
AMGNAMGEN INC64,201$20.1Mshares
BIIBBIOGEN INC76,726$17.8Mshares
KVUEKENVUE INC960,400$17.5Mshares
TEVATEVA PHARMACEUTICAL INDS LTD911,900$14.8Mshares
CYTKCYTOKINETICS INC236,900$12.8Mshares
CRSPCRISPR THERAPEUTICS AG201,497$10.9Mshares
AVTRAVANTOR INC400,000$8.48Mshares
PFEPFIZER INC185,200$5.18Mshares
EOLSEVOLUS INC465,300$5.05Mshares
SRPTSAREPTA THERAPEUTICS INC20,000$3.16Mcall

How Q3 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001214659-24-019126 base2024-11-14acceptance time not in the bulk data set